|
|
阿托品在青少年近视防控中的应用
|
Abstract:
近视是导致儿童青少年致盲的主要原因，目前全世界尚没有发现可以治愈近视的方法，但我们可以采取干预措施来预防或延缓近视的发生或进展，尽可能减少高度近视人群及其相关并发症，让更多的儿童青少年拥有视力，不致于发生失明。故寻找行之有效的近视防控措施十分必要，而低浓度阿托品作为延缓近视进展的主要药物，对其进行深入研究极其重要。该综述就低浓度阿托品滴眼液在延缓近视进展中的作用机制、临床应用及其不良反应进行详细阐述。
Myopia is the main cause of blindness among children and adolescents. At present, there is no method to cure myopia in the world, but we can take intervention measures to prevent or delay the occurrence or progress of myopia, reduce the number of people with high myopia and its related complications as much as possible, so that more children and adolescents can have vision without blindness. Therefore, it is necessary to find effective measures to prevent and control myopia. As the main drug to delay the progress of myopia, it is extremely important to conduct in-depth research on low concentration atropine. In this review, the mechanism, clinical application and adverse reactions of low concentration atropine eye drops in delaying the progress of myopia were described in detail.
| [1] | World Health Organization (2019) International Statistical Classification of Diseases and Related Health Problems (ICD-11). WHO, Geneva. https://www.who.int/news-room/detail/25-05-2019-world-health-assembly-update |
| [2] | Morgan, I.G., French, A.N., Ashby, R.S., Guo, X., Ding, X., He, M. and Rose, K.A. (2018) The Epidemics of Myopia: Aetiology and Prevention. Progress in Retinal and Eye Research, 62, 134-149.
https://doi.org/10.1016/j.preteyeres.2017.09.004 |
| [3] | Dong, L., Kang, Y.K., Li, Y., Wei, W.B. and Jonas, J.B. (2020) Prevalence and Time Trends of Myopia in Children and Adolescents in China: A Systemic Review and Meta-Analysis. Retina, 40, 399-411.
https://doi.org/10.1097/IAE.0000000000002590 |
| [4] | Saw, S.-M., Gazzard, G., Shih-Yen, E.C. and Chua, W.-H. (2005) Myopia and Associated Pathological Complications. Ophthalmic and Physiological Optics, 25, 381-391. https://doi.org/10.1111/j.1475-1313.2005.00298.x |
| [5] | Grzybowski, A., Kanclerz, P., Tsubota, K., Lanca, C. and Saw, S.M. (2020) A Review on the Epidemiology of Myopia in School Children Worldwide. BMC Ophthalmology, 20, Article No. 27. https://doi.org/10.1186/s12886-019-1220-0 |
| [6] | Cooper, J. and Tkatchenko, A.V. (2018) A Review of Current Concepts of the Etiology and Treatment of Myopia. Eye & Contact Lens: Science & Clinical Practice, 44, 231-247. https://doi.org/10.1097/ICL.0000000000000499 |
| [7] | Sato, T. (1993) The Cause and Prevention of School Myopia. Excerpta Mediea, Amsterdam, 28-58. |
| [8] | 瞿佳. 近视防控瞿佳2020观点[M]. 北京: 科学技术文献出版社, 2020: 90. |
| [9] | MeBrien, N.A., Stell, W.K. and Carr, B. (2013) How Does Atropine Exert Its Anti·Myopia Effects? Ophthalmic and Physiological Optics, 33(3): 373-378. https://doi.org/10.1111/opo.12052 |
| [10] | Arumugam, B. and McBrien, N.A. (2012) Muscarinic Antagonist Control of Myopia: Evidence for M4 and M1 Receptor-Based Pathways in the Inhibition of Experimentally-Induced Axial Myopia in the Tree Shrew. Investigative Ophthalmology & Visual Science, 53, 5827-5837. https://doi.org/10.1167/iovs.12-9943 |
| [11] | Barathi, V.A., Chaurasia, S.S., Poidinger, M., et al. (2014) Involvement of GABA Transporters in Atropine-Treated Myopic Retina As Revealed by iTRAQ Quantitative Proteomics. Journal of Proteome Research, 13, 4647-4658.
https://doi.org/10.1021/pr500558y |
| [12] | McBrien, N.A., Moghaddam, H.O. and Reeder, A.P. (1993) Atropine Reduces Experimental Myopia and Eye Enlargement via a Nonaccommodative Mechanism. Investigative Ophthalmology & Visual Science, 34, 205-215. |
| [13] | Zhang, S., Yang, J., Reinach, P.S., et al. (2018) Dopamine Receptor Subtypes Mediate Opposing Effects on Form Deprivation Myopia in Pigmented Guinea Pigs. Investigative Ophthalmology & Visual Science, 59, 4441-4448.
https://doi.org/10.1167/iovs.17-21574 |
| [14] | Carr, B.J. and Stell, W.K. (2016) Nitric Oxide (NO) Mediates the Inhibition of Form-Deprivation Myopia by Atropine in Chicks. Scientific Reports, 6, Article No. 9. https://doi.org/10.1038/s41598-016-0002-7 |
| [15] | Marzani, D. and Wallman, J. (1997) Growth of the Two Layers of the Chick Sclera Is Modulated Reciprocally by Visual Conditions. Investigative Ophthalmology & Visual Science, 38, 1726-1739. |
| [16] | Zhou, X., Zhang, S., Zhang, G., et al. (2020) IIncreased Choroidal Blood Perfusion Can Inhibit Form Deprivation Myopia in Guinea Pigs. Investigative Ophthalmology & Visual Science, 61, Article No. 25.
https://doi.org/10.1167/iovs.61.13.25 |
| [17] | Zhu, Q., Goto, S., Singh, S., Torres, J.A. and Wildsoet, C.F. (2022) Daily or Less Frequent Topical 1% Atropine Slows Defocus-Induced Myopia Progression in Contact Lens-Wearing Guinea Pigs. Translational Vision Science & Technology, 11, Article No. 26. https://doi.org/10.1167/tvst.11.3.26 |
| [18] | Chiang, S.T.-H. and Phillips, J.R. (2018) Effect of Atropine Eye Drops on Choroidal Thinning Induced by Hyperopic Retinal Defocus. Journal of Ophthalmology, 2018, Article ID: 8528315. https://doi.org/10.1155/2018/8528315 |
| [19] | Barathi, V.A., Weon, S.R. and Beuerman, R.W. (2009) Expression of Muscarinic Receptors in Human and Mouse Sclera and Their Role in the Regulation of Scleral Fibro-Blasts Proliferation. Molecular Vision, 15, 1277-1293. |
| [20] | Gallego, P., Martínez-García, C., Pérez-Merino, P., et al. (2012) Scleral Changes Induced by Atropine in Chicks as an Experimental Model of Myopia. Ophthalmic and Physiological Optics, 32, 478-484.
https://doi.org/10.1111/j.1475-1313.2012.00940.x |
| [21] | Barathi, V.A. and Beuerman, R.W. (2011) Molecular Mechanisms of Muscarinic Receptors in Mouse Scleral Fibroblasts: Prior to and after Induction of Experimental Myopia with Atropine Treatment. Molecular Vision, 17, 680-691. |
| [22] | Lind, G.J., Chew, S.J., Marzani, D. and Wallman, J. (1998) Muscarinic Acetylcholine Receptor Antagonists Inhibit Chick Scleral Chondrocytes. Investigative Ophthalmology & Visual Science, 39, 2217-2231. |
| [23] | Feldkaemper, M. and Schaeffel, F. (2013) An Updated View on the Role of Dopamine in Myopia. Experimental Eye Research, 114, 106-119. https://doi.org/10.1016/j.exer.2013.02.007 |
| [24] | Shih, Y.F., Chen, C.H., Chou, A.C., et al. (1999) Effects of Different Concentrations of Atropine on Controlling Myopia in Myopic Children. Journal of Ocular Pharmacology and Therapeutics, 15, 85-90.
https://doi.org/10.1089/jop.1999.15.85 |
| [25] | Chua, W.-H., Balakrishnan, V., Chan, Y.-H., et al. (2006) Atropine for the Treatment of Childhood Myopia. Ophthalmology, 113, 2285-2291. https://doi.org/10.1016/j.ophtha.2006.05.062 |
| [26] | Chia, A., Chua, W.-H., Cheung, Y.-B., et al. (2012) Atropine for the Treatment of Childhood Myopia: Safety and Efficacy of 0.5%, 0.1%, and 0.01% Doses (Atropine for the Treatment of Myopia 2). Ophthalmology, 119, 347-354.
https://doi.org/10.1016/j.ophtha.2011.07.031 |
| [27] | Yam, J.C., Jiang, Y., Tang, S.M., et al. (2010) Low-Concentration Atropine for Myopia Progression (LAMP) Study A Randomized, Double-Blinded, Placebo-Controlled Trial of 0.05%, 0.025%, and 0.01% Atropine Eye Drops in Myopia Control. Ophthalmology, 126, 113-124. https://doi.org/10.1016/j.ophtha.2018.05.029 |
| [28] | Yam, J.C., Li, F.F., Zhang, X., et al. (2020) Two-Year Clinical Trial of the Low-Concentration Atropine for Myopia Progression (LAMP) Study: Phase 2 Report. Ophthalmology, 127, 910-919.
https://doi.org/10.1016/j.ophtha.2019.12.011 |
| [29] | Fu, A., Stapleton, F., et al. (2020) Effect of Low-Dose Atropine on Myopia Progression, Pupil Diameter and Accommodative Amplitude: Low-Dose Atropine and Myopia Progression. British Journal of Ophthalmology, 104, 1535-1541. https://doi.org/10.1136/bjophthalmol-2019-315440 |
| [30] | 李静一, 刘芙蓉, 周晓伟, 李长安, 胡晓洁. 0.01%阿托品对学龄期儿童近视防控作用研究[J]. 中国学校卫生, 2018, 39(3): 432-435. https://doi.org/10.16835/j.cnki.1000-9817.2018.03.032 |
| [31] | Huang, J., Wen, D., Wang, Q., et al. (2016) Efficacy Comparison of 16 Interventions for Myopia Control in Children: A Network Meta-Analysis. Ophthalmology, 123, 697-708. https://doi.org/10.1016/j.ophtha.2015.11.010 |
| [32] | Walline, J.J. (2016) Myopia Control: A Review. Eye & Contact Lens: Science & Clinical Practice, 42, 3-8.
https://doi.org/10.1097/ICL.0000000000000207 |
| [33] | Cooper, J., Eisenberg, N., Schulman, E. and Wang, F.M. (2013) Maximum Atropine Dose without Clinical Signs or Symptoms. Optometry and Vision Science, 90, 1467-1472. https://doi.org/10.1097/OPX.0000000000000037 |
| [34] | Kaymak, H., Fricke, A., Mauritz, Y., et al. (2018) Short-Term Effects of Low-Concentration Atropine Eye Drops on Pupil Size and Accommodation in Young Adult Subjects. Graefe’s Archive for Clinical and Experimental Ophthalmology, 256, 2211-7. https://doi.org/10.1007/s00417-018-4112-8 |
| [35] | 张艳玲, 查屹, 邢丽娟, 陈佳琪. 0.01%低浓度阿托品滴眼液对近视儿童调节功能和视疲劳的影响研究[J]. 中国斜视与小儿眼科杂志, 2021, 29(3): 7-10. https://doi.org/10.3969/J.ISSN.1005-328X.2021.03.003 |
| [36] | Wen, Q., Fan, T.-J. and Tian, C.-L. (2016) Cytotoxicity of Atropine to Human Corneal Endothelial Cells by Inducing Mitochondrion-Dependent Apoptosis. Experimental Biology and Medicine, 241, 1457-1465.
https://doi.org/10.1177/1535370216640931 |
| [37] | Zhao, Q. and Hao, Q. (2021) Clinical Efficacy of 0.01% Atropine in Retarding the Progression of Myopia in Children. International Ophthalmology, 41, 1011-1017. https://doi.org/10.1007/s10792-020-01658-0 |
| [38] | Gong, Q., Janowski, M., Luo, M., et al. (2017) Efficacy and Adverse Effects of Atropine in Childhood Myopia: A Meta-Analysis. JAMA Ophthalmology, 135, 624-630. https://doi.org/10.1001/jamaophthalmol.2017.1091 |
